OBJECTIVES: We tested the efficacy of a combined pharmacologic and behavioral smoking cessation intervention among women in a state prison in the southern United States. METHODS: The study design was a randomized controlled trial with a 6-month waitlist control group. The intervention was a 10-week group intervention combined with nicotine replacement therapy. Two hundred and fifty participants received the intervention, and 289 were in the control group. Assessments occurred at baseline; end of treatment; 3, 6, and 12 months after treatment; and at weekly sessions for participants in the intervention group. RESULTS: The intervention was efficacious compared with the waitlist control group. Point prevalence quit rates for the intervention group were 18% at end of treatment, 17% at 3-month follow-up, 14% at 6-month follow-up, and 12% at 12-month follow-up, quit rates that are consistent with outcomes from community smoking-cessation interventions. CONCLUSIONS:Female prisoners are interested in smoking cessation interventions and achieved point-prevalence quit rates similar to community samples. Augmenting tobacco control policies in prison with smoking cessation interventions has the potential to address a significant public health need.
RCT Entities:
OBJECTIVES: We tested the efficacy of a combined pharmacologic and behavioral smoking cessation intervention among women in a state prison in the southern United States. METHODS: The study design was a randomized controlled trial with a 6-month waitlist control group. The intervention was a 10-week group intervention combined with nicotine replacement therapy. Two hundred and fifty participants received the intervention, and 289 were in the control group. Assessments occurred at baseline; end of treatment; 3, 6, and 12 months after treatment; and at weekly sessions for participants in the intervention group. RESULTS: The intervention was efficacious compared with the waitlist control group. Point prevalence quit rates for the intervention group were 18% at end of treatment, 17% at 3-month follow-up, 14% at 6-month follow-up, and 12% at 12-month follow-up, quit rates that are consistent with outcomes from community smoking-cessation interventions. CONCLUSIONS: Female prisoners are interested in smoking cessation interventions and achieved point-prevalence quit rates similar to community samples. Augmenting tobacco control policies in prison with smoking cessation interventions has the potential to address a significant public health need.
Authors: Robyn L Richmond; Tony Butler; Josephine M Belcher; Alex Wodak; Kay A Wilhelm; Eli Baxter Journal: Aust N Z J Public Health Date: 2006-10 Impact factor: 2.939
Authors: Karen L Cropsey; Michael F Weaver; Gloria D Eldridge; Gabriela C Villalobos; Al M Best; Maxine L Stitzer Journal: Nicotine Tob Res Date: 2009-04-22 Impact factor: 4.244
Authors: Ross M Kauffman; Amy K Ferketich; David M Murray; Paul E Bellair; Mary Ellen Wewers Journal: Nicotine Tob Res Date: 2011-03-29 Impact factor: 4.244
Authors: Jerry M Suls; Tana M Luger; Susan J Curry; Robin J Mermelstein; Amy K Sporer; Larry C An Journal: Am J Prev Med Date: 2012-06 Impact factor: 5.043
Authors: Oscar V Torres; Joseph A Pipkin; Patrick Ferree; Luis M Carcoba; Laura E O'Dell Journal: Nicotine Tob Res Date: 2015-03-11 Impact factor: 4.244
Authors: Ank E Nijhawan; Rachel Salloway; Amy S Nunn; Michael Poshkus; Jennifer G Clarke Journal: J Womens Health (Larchmt) Date: 2010-01 Impact factor: 2.681